Theravance Biopharma Inc (TBPH)
9.61
-0.36
(-3.61%)
USD |
NASDAQ |
Nov 21, 16:00
9.62
+0.01
(+0.10%)
After-Hours: 20:00
Theravance Biopharma Market Cap: 472.56M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 472.56M |
| November 20, 2024 | 490.27M |
| November 19, 2024 | 487.81M |
| November 18, 2024 | 466.66M |
| November 15, 2024 | 468.14M |
| November 14, 2024 | 470.60M |
| November 13, 2024 | 476.01M |
| November 12, 2024 | 438.14M |
| November 11, 2024 | 446.50M |
| November 08, 2024 | 439.62M |
| November 07, 2024 | 430.27M |
| November 06, 2024 | 428.31M |
| November 05, 2024 | 406.67M |
| November 04, 2024 | 403.72M |
| November 01, 2024 | 407.16M |
| October 31, 2024 | 405.19M |
| October 30, 2024 | 416.50M |
| October 29, 2024 | 425.36M |
| October 28, 2024 | 431.26M |
| October 25, 2024 | 420.44M |
| October 24, 2024 | 424.86M |
| October 23, 2024 | 424.37M |
| October 22, 2024 | 432.73M |
| October 21, 2024 | 425.85M |
| October 18, 2024 | 432.73M |
| Date | Value |
|---|---|
| October 17, 2024 | 423.88M |
| October 16, 2024 | 427.81M |
| October 15, 2024 | 422.90M |
| October 14, 2024 | 404.70M |
| October 11, 2024 | 408.64M |
| October 10, 2024 | 396.34M |
| October 09, 2024 | 396.34M |
| October 08, 2024 | 389.95M |
| October 07, 2024 | 395.85M |
| October 04, 2024 | 398.31M |
| October 03, 2024 | 398.31M |
| October 02, 2024 | 403.72M |
| October 01, 2024 | 403.72M |
| September 30, 2024 | 396.34M |
| September 27, 2024 | 396.27M |
| September 26, 2024 | 394.31M |
| September 25, 2024 | 389.42M |
| September 24, 2024 | 392.36M |
| September 23, 2024 | 388.44M |
| September 20, 2024 | 391.87M |
| September 19, 2024 | 401.65M |
| September 18, 2024 | 404.59M |
| September 17, 2024 | 403.12M |
| September 16, 2024 | 397.25M |
| September 13, 2024 | 398.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
374.74M
Minimum
Aug 09 2024
1.934B
Maximum
Apr 29 2020
832.29M
Average
693.30M
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 5.859B |
| Madrigal Pharmaceuticals Inc | 7.181B |
| Ionis Pharmaceuticals Inc | 5.359B |
| Jazz Pharmaceuticals PLC | 7.563B |
| NovaBay Pharmaceuticals Inc | 3.517M |
Market Cap Related Metrics
| PS Ratio | 7.430 |
| PEG Ratio | -1.506 |
| Price to Book Value | 2.545 |
| Price | 9.61 |
| Earnings Yield | -10.51% |
| PEGY Ratio | -1.506 |